URS
BIIB icon

Utah Retirement Systems’s Biogen BIIB Stock Holding History

Utah Retirement Systems’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.35M Sell
23,714
-282
-1% -$52K 0.04% 354
2025
Q4 		$4.22M Hold
23,996
– – 0.04% 371
2025
Q3 		$3.36M Hold
23,996
– – 0.03% 438
2025
Q2 		$3.01M Sell
23,996
-119
-0.5% -$14.8K 0.03% 455
2025
Q1 		$3.3M Hold
24,115
– – 0.04% 409
2024
Q4 		$3.69M Hold
24,115
– – 0.04% 387
2024
Q3 		$4.67M Buy
24,115
+100
+0.4% +$20.9K 0.05% 329
2024
Q2 		$5.57M Sell
24,015
-900
-4% -$196K 0.07% 279
2024
Q1 		$5.37M Hold
24,915
– – 0.06% 299
2023
Q4 		$6.45M Buy
24,915
+100
+0.4% +$24.6K 0.08% 245
2023
Q3 		$6.38M Buy
24,815
+49
+0.2% +$13.1K 0.09% 219
2023
Q2 		$7.05M Sell
24,766
-800
-3% -$238K 0.1% 202
2023
Q1 		$7.11M Buy
25,566
+100
+0.4% +$27.7K 0.1% 202
2022
Q4 		$7.05M Sell
25,466
-663
-3% -$187K 0.11% 188
2022
Q3 		$6.98M Buy
26,129
+100
+0.4% +$21.2K 0.12% 175
2022
Q2 		$5.31M Hold
26,029
– – 0.09% 236
2022
Q1 		$5.48M Sell
26,029
-500
-2% -$109K 0.07% 268
2021
Q4 		$6.37M Sell
26,529
-300
-1% -$77.1K 0.08% 255
2021
Q3 		$7.59M Sell
26,829
-1,700
-6% -$557K 0.1% 191
2021
Q2 		$9.88M Sell
28,529
-600
-2% -$182K 0.13% 157
2021
Q1 		$8.15M Sell
29,129
-1,600
-5% -$432K 0.11% 167
2020
Q4 		$7.52M Buy
30,729
+455
+2% +$117K 0.11% 180
2020
Q3 		$8.59M Sell
30,274
-700
-2% -$195K 0.14% 144
2020
Q2 		$8.29M Sell
30,974
-3,100
-9% -$932K 0.15% 139
2020
Q1 		$10.8M Sell
34,074
-300
-0.9% -$91K 0.23% 95
2019
Q4 		$10.2M Sell
34,374
-600
-2% -$166K 0.18% 121
2019
Q3 		$8.14M Sell
34,974
-1,800
-5% -$419K 0.15% 142
2019
Q2 		$8.6M Sell
36,774
-341
-0.9% -$78.7K 0.16% 129
2019
Q1 		$8.77M Sell
37,115
-399
-1% -$126K 0.17% 118
2018
Q4 		$11.3M Buy
37,514
+100
+0.3% +$31.9K 0.26% 81
2018
Q3 		$13.2M Sell
37,414
-1,600
-4% -$551K 0.26% 78
2018
Q2 		$11.3M Sell
39,014
-500
-1% -$141K 0.23% 83
2018
Q1 		$10.8M Buy
39,514
+100
+0.3% +$31K 0.23% 91
2017
Q4 		$12.6M Buy
39,414
+500
+1% +$160K 0.26% 81
2017
Q3 		$12.2M Hold
38,914
– – 0.27% 78
2017
Q2 		$10.6M Sell
38,914
-1,200
-3% -$317K 0.25% 89
2017
Q1 		$11M Hold
40,114
– – 0.26% 83
2016
Q4 		$11.4M Hold
40,114
– – 0.29% 73
2016
Q3 		$12.6M Hold
40,114
– – 0.33% 62
2016
Q2 		$9.7M Hold
40,114
– – 0.26% 83
2016
Q1 		$10.4M Hold
40,114
– – 0.28% 72
2015
Q4 		$12.3M Sell
40,114
-2,000
-5% -$575K 0.33% 62
2015
Q3 		$12.3M Buy
42,114
+200
+0.5% +$66K 0.35% 60
2015
Q2 		$16.9M Sell
41,914
-600
-1% -$241K 0.45% 46
2015
Q1 		$18M Buy
42,514
+1,400
+3% +$552K 0.47% 44
2014
Q4 		$14M Hold
41,114
– – 0.38% 52
2014
Q3 		$13.6M Sell
41,114
-100
-0.2% -$33K 0.39% 49
2014
Q2 		$13M Sell
41,214
-1,500
-4% -$451K 0.37% 51
2014
Q1 		$13.1M Buy
42,714
+400
+0.9% +$127K 0.38% 54
2013
Q4 		$11.8M Sell
42,314
-100
-0.2% -$25.9K 0.35% 58
2013
Q3 		$10.2M Sell
42,414
-300
-0.7% -$67.1K 0.33% 61
2013
Q2 		$9.19M Buy
+42,714
New +$9.13M 0.31% 63

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Utah Retirement Systems's BIIB Position: Q1 2026 in Review

Utah Retirement Systems reduced its Biogen (BIIB) stake by 1.2% in Q1 2026, selling an estimated $52K and leaving 23,714 shares worth $4.35M. The position accounts for 0.04% of the portfolio, ranked #354.

Utah Retirement Systems first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $18M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Utah Retirement Systems held 23,714 shares of Biogen worth $4.35M as of Q1 2026.
  • Utah Retirement Systems sold 282 Biogen shares in Q1 2026, an estimated $52K.
  • Biogen made up 0.04% of Utah Retirement Systems's portfolio in Q1 2026, its #354 holding.
  • Utah Retirement Systems first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Utah Retirement Systems's Biogen position peaked at $18M in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.